← Browse by Condition
Medical Condition
crs cytokine release syndrome
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for crs cytokine release syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT07106671 Phase 2
Recruiting
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Enrollment
20 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06377059
Recruiting
Early Detection of Complications During Immunotherapy for Haematological Malignancy
Enrollment
100 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology